Work

Diagnostics and therapeutics: the CRISPR story continues

Year: 2026

Type: article

Abstract: The last time The Lancet Microbe featured an Editorial on CRISPR was in November 2020, to mark that year’s Nobel Prize in Chemistry, jointly awarded to Emmanuelle Charpentier and Jennifer A Doudna for their work developing CRISPR-Cas9 genome editing technology.

Source: The Lancet Microbe

DOI: 10.1016/j.lanmic.2026.101417

Author: The Lancet Microbe

Language: English

Topic: CRISPR and Genetic Engineering

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

Open Access status: gold

Estimated APC paid: $7,280

OpenAlex ID: W7152712665

FWCI:

Cites:

Cited by:

Related to: